Shereen Oon

1.0k total citations
33 papers, 469 citations indexed

About

Shereen Oon is a scholar working on Rheumatology, Immunology and Neurology. According to data from OpenAlex, Shereen Oon has authored 33 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Rheumatology, 15 papers in Immunology and 7 papers in Neurology. Recurrent topics in Shereen Oon's work include Systemic Lupus Erythematosus Research (18 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and T-cell and B-cell Immunology (7 papers). Shereen Oon is often cited by papers focused on Systemic Lupus Erythematosus Research (18 papers), Atherosclerosis and Cardiovascular Diseases (7 papers) and T-cell and B-cell Immunology (7 papers). Shereen Oon collaborates with scholars based in Australia, United States and United Kingdom. Shereen Oon's co-authors include Mandana Nikpour, Ian P. Wicks, Nicholas J. Wilson, Molla Huq, Eric F. Morand, Vera Golder, Jessica Fairley, Amanda Saracino, John G. Hanly and Milica Ng and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Seminars in Arthritis and Rheumatism.

In The Last Decade

Shereen Oon

24 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shereen Oon Australia 13 329 253 101 68 48 33 469
Francesca Saccon Italy 12 481 1.5× 308 1.2× 160 1.6× 38 0.6× 81 1.7× 23 575
Regina Kurrasch United States 12 266 0.8× 188 0.7× 127 1.3× 57 0.8× 74 1.5× 21 534
M. Safy Netherlands 7 240 0.7× 149 0.6× 62 0.6× 32 0.5× 38 0.8× 10 375
C-S Yee United Kingdom 7 395 1.2× 210 0.8× 94 0.9× 23 0.3× 70 1.5× 10 452
Kateryna Vostretsova Canada 5 378 1.1× 231 0.9× 54 0.5× 23 0.3× 86 1.8× 5 448
Gro Østli Eilertsen Norway 11 243 0.7× 247 1.0× 68 0.7× 62 0.9× 25 0.5× 22 367
L De Rycke Belgium 8 469 1.4× 162 0.6× 215 2.1× 55 0.8× 35 0.7× 15 610
Teresa Aberle United States 11 346 1.1× 351 1.4× 84 0.8× 44 0.6× 49 1.0× 24 533
L M Vilá Puerto Rico 5 439 1.3× 188 0.7× 80 0.8× 27 0.4× 76 1.6× 7 507
Cristina Pamfil Romania 13 348 1.1× 216 0.9× 61 0.6× 28 0.4× 107 2.2× 43 502

Countries citing papers authored by Shereen Oon

Since Specialization
Citations

This map shows the geographic impact of Shereen Oon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shereen Oon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shereen Oon more than expected).

Fields of papers citing papers by Shereen Oon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shereen Oon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shereen Oon. The network helps show where Shereen Oon may publish in the future.

Co-authorship network of co-authors of Shereen Oon

This figure shows the co-authorship network connecting the top 25 collaborators of Shereen Oon. A scholar is included among the top collaborators of Shereen Oon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shereen Oon. Shereen Oon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oon, Shereen, et al.. (2025). Imaging findings of scleroderma-associated myopathy: A systematic literature review. Seminars in Arthritis and Rheumatism. 72. 152672–152672.
2.
Oon, Shereen, et al.. (2025). Outcomes of rheumatology referrals seen in a general medicine clinic. Internal Medicine Journal. 55(12). 2053–2058.
3.
Hao, Yanjie, et al.. (2024). Systematic review of treatments for the gastrointestinal manifestations of systemic lupus erythematosus. Seminars in Arthritis and Rheumatism. 69. 152567–152567.
4.
Nikpour, Mandana, et al.. (2024). Diagnosing and characterizing inflammatory myopathies at an Australian tertiary public hospital: Resource utilization and direct healthcare costs. International Journal of Rheumatic Diseases. 27(4). e15153–e15153.
5.
Hao, Yanjie, Shereen Oon, & Mandana Nikpour. (2024). Efficacy and safety of treat-to-target strategy studies in rheumatic diseases: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 67. 152465–152465. 6 indexed citations
6.
Oon, Shereen, et al.. (2024). Patient experiences of muscle biopsy in idiopathic inflammatory myopathies: a cross-sectional survey. Rheumatology International. 44(10). 2129–2137.
7.
Taylor, Lynne, Dylan Hansen, Kathleen Morrisroe, et al.. (2024). Impact of Season, Environmental Temperature, and Humidity on Raynaud Phenomenon in an Australian Systemic Sclerosis Cohort. Arthritis Care & Research. 77(1). 61–68.
8.
Morrisroe, Kathleen, et al.. (2024). Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review. Seminars in Arthritis and Rheumatism. 68. 152471–152471. 2 indexed citations
9.
Hoi, Alberta, Cristina Gamell, Tsin Yee Tai, et al.. (2023). CSL362 potently and specifically depletes pDCs in vitro and ablates SLE-immune complex-induced IFN responses. iScience. 26(7). 107173–107173. 9 indexed citations
10.
Hao, Yanjie, Shereen Oon, Lanlan Ji, et al.. (2021). Determinants and protective associations of the lupus low disease activity state in a prospective Chinese cohort. Clinical Rheumatology. 41(2). 357–366. 15 indexed citations
11.
12.
Oon, Shereen, et al.. (2020). Management of inflammatory neurologic and psychiatric manifestations of systemic lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism. 51(1). 49–71. 24 indexed citations
13.
Aranow, Cynthia, Anca Askanase, Shereen Oon, et al.. (2020). Laboratory investigation results influence Physician's Global Assessment (PGA) of disease activity in SLE. Annals of the Rheumatic Diseases. 79(6). 787–792. 16 indexed citations
14.
Fairley, Jessica, Shereen Oon, Amanda Saracino, & Mandana Nikpour. (2019). Management of cutaneous manifestations of lupus erythematosus: A systematic review. Seminars in Arthritis and Rheumatism. 50(1). 95–127. 37 indexed citations
15.
Patel, Shreeya, Laura Ross, Shereen Oon, & Mandana Nikpour. (2018). Rituximab treatment in primary angiitis of the central nervous system. Internal Medicine Journal. 48(6). 724–727. 4 indexed citations
16.
Aranow, Cynthia, Anca Askanase, Molla Huq, et al.. (2018). Laboratory Investigation Results Influence Physician's Global Assessment of Disease Activity in Systemic Lupus Erythematosus. Arthritis & Rheumatism. 70.
17.
18.
Oon, Shereen, Huy Huynh, Tsin Yee Tai, et al.. (2016). A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 1(6). e86131–e86131. 26 indexed citations
19.
Mohan, Helen, Lynda Fenelon, Naomi Fearon, et al.. (2012). Plastic wound retractors as bacteriological barriers in gastrointestinal surgery: a prospective multi-institutional trial. Journal of Hospital Infection. 81(2). 109–113. 11 indexed citations
20.
Oon, Shereen, et al.. (2006). Acute copper toxicity following copper glycinate injection. Internal Medicine Journal. 36(11). 741–743. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026